Meet Dan Thomas, CEO and Founding Consultant at Twenty24 Consulting. He uses his 25 years’ experience as a drug discovery professional to help his clients—from early academic spin-outs to AI driven drug discovery—with data quality, particularly around reproducibility, digit(al)ization , and the importance of multi-parametric information. An interview brought to you by Emily, co-author of the Synthesis newsletter.